NO20075943L - Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner - Google Patents

Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner

Info

Publication number
NO20075943L
NO20075943L NO20075943A NO20075943A NO20075943L NO 20075943 L NO20075943 L NO 20075943L NO 20075943 A NO20075943 A NO 20075943A NO 20075943 A NO20075943 A NO 20075943A NO 20075943 L NO20075943 L NO 20075943L
Authority
NO
Norway
Prior art keywords
azithromycin
medicament
treatment
manufacture
eye infections
Prior art date
Application number
NO20075943A
Other languages
English (en)
Inventor
Jacques Luyckx
Jacques Pilotaz
Pablo Goldschmidt
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075943(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of NO20075943L publication Critical patent/NO20075943L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives anvendelse av azitromycin for industriell fremstilling av et medikament for behandling av okulære infeksjoner, i det vesentlige bestående av azitromycin i oppløsning i en farmasøytisk akseptabel vehikkel av middelskjede fettsyretriglycerider, ved en konsentrasjon på 1% til 2%, for topisk applikasjon to ganger daglig i hvert øye som skal behandles, i mindre enn fire dager.
NO20075943A 2005-04-22 2007-11-19 Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner NO20075943L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
PCT/IB2006/000963 WO2006111844A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires

Publications (1)

Publication Number Publication Date
NO20075943L true NO20075943L (no) 2008-01-15

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075943A NO20075943L (no) 2005-04-22 2007-11-19 Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner

Country Status (25)

Country Link
US (2) US20060252711A1 (no)
EP (1) EP1877066A1 (no)
JP (1) JP2008536908A (no)
KR (1) KR20080008377A (no)
CN (1) CN101163486B (no)
AR (1) AR053591A1 (no)
AU (1) AU2006238595A1 (no)
BR (1) BRPI0608375A2 (no)
CA (1) CA2603833A1 (no)
EA (1) EA200702295A1 (no)
FR (1) FR2884716B1 (no)
HK (1) HK1119064A1 (no)
IL (1) IL186092A (no)
JO (1) JO3448B1 (no)
MA (1) MA29467B1 (no)
MX (1) MX2007013054A (no)
MY (1) MY169533A (no)
NO (1) NO20075943L (no)
PE (1) PE20070157A1 (no)
SG (1) SG164382A1 (no)
TN (1) TNSN07370A1 (no)
TW (1) TWI430799B (no)
UA (1) UA94708C2 (no)
WO (1) WO2006111844A1 (no)
ZA (1) ZA200709872B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505855A (ja) * 1996-12-09 2001-05-08 ボシュ アンド ロム インコーポレイテッド 使い捨て可撓容器
DE69825128T3 (de) * 1997-12-02 2010-05-06 Pfizer Products Inc., Groton Verwendung von azithromycin zur topischen behandlung von augeninfektionen
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
MY169533A (en) 2019-04-22
WO2006111844A1 (fr) 2006-10-26
CN101163486B (zh) 2011-11-30
AU2006238595A1 (en) 2006-10-26
BRPI0608375A2 (pt) 2010-08-31
CA2603833A1 (fr) 2006-10-26
ZA200709872B (en) 2008-09-25
TNSN07370A1 (fr) 2009-03-17
FR2884716B1 (fr) 2009-08-21
JO3448B1 (ar) 2020-07-05
IL186092A0 (en) 2008-01-20
US20060252711A1 (en) 2006-11-09
TW200716142A (en) 2007-05-01
PE20070157A1 (es) 2007-03-09
AR053591A1 (es) 2007-05-09
EP1877066A1 (fr) 2008-01-16
US20100069315A1 (en) 2010-03-18
UA94708C2 (ru) 2011-06-10
IL186092A (en) 2016-05-31
MA29467B1 (fr) 2008-05-02
HK1119064A1 (en) 2009-02-27
CN101163486A (zh) 2008-04-16
EA200702295A1 (ru) 2008-04-28
FR2884716A1 (fr) 2006-10-27
MX2007013054A (es) 2008-01-14
TWI430799B (zh) 2014-03-21
KR20080008377A (ko) 2008-01-23
SG164382A1 (en) 2010-09-29
JP2008536908A (ja) 2008-09-11

Similar Documents

Publication Publication Date Title
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
TW200833330A (en) Substituted dihydropyrazolones and their use
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
ECSP055844A (es) Nuevos compuestos triciclicos
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
RU2012103458A (ru) Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций
WO2005117913A3 (en) Ozonized pharmaceutical composition and method
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
NO20092018L (no) Fremgangsmater for a behandle depresjon
NO20075943L (no) Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner
AR055939A1 (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
WO2007022642A3 (en) Anti-inflammatory molecules and their uses
WO2007095609A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
BR0313589A (pt) Uso de extrato de germe de trigo fermentado como agente antiinflamatório
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine
DE502006008777D1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien
ATE284209T1 (de) Verwendung einer pharmazeutischen zusammensetzung zur herstellung eines medikamentes zur behandlung von durch bakterien, viren, pilze, hefen und/oder protozoen verursachten augenerkrankungen
WO2007144889A3 (en) Treatment of neurofibromatosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application